Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MPX International

MPX International
2015 FOUNDED
M&A STATUS
PIPE LATEST DEAL TYPE
6 FINANCING ROUNDS
10 INVESTMENTS
Description

Operator of a vertically integrated, global cannabis company intended to focus on developing and operating assets with an emphasis on cultivating, manufacturing and distributing its products. The company has an established presence in six markets including Australia, Canada, Malta, South Africa, Switzerland and the United Kingdom and a diversified asset base targeting medical, health and wellness and recreational channels. Its brands include HolyWeed and Salus BioPharma.

Formerly Known As
The Canadian Bioceutical, MPX Bioceutical
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • 5255 Yonge Street
  • Suite 701, North York
  • Toronto, Ontario M2N 6P4
  • Canada

MPX International Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore MPX International‘s full profile, request access.

Request full access to PitchBook

MPX International Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Canopy Growth Corporate Backed or Acquired Smiths Falls, Canada 0000 00000 000000&0 00000
000000 00000000 Corporation Cremona, Canada 0000 000 000000000 000
To view this company’s complete list of competitors, request access »

MPX International Investments & Acquisitions (10)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 0000000 16-Aug-2019 000000000000000000 Pharmaceuticals
00000000 17-May-2019 000000000000000000 00.00 Cultivation
0000000 00000000 22-Oct-2018 000000000000000000 000 Other Healthcare Services 00000 00000
000000-00000 00000 10-Oct-2018 00000 0000000 Pharmaceuticals
Canveda 11-Jun-2018 Merger/Acquisition 0000 Other Consumer Non-Durables 00000 00000
To view this company’s complete investment and acquisition history, request access »

MPX International Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 00 00000 11-Dec-2017 000000000000000000 000.00 Completed
  • 000 0000000000000
To view this company’s complete exits history, request access »

MPX International Subsidiaries (3)

Company Name Industry Location Founded
Spartan Wellness Other Healthcare Services Toronto, Canada 2017
0000000 Other Consumer Non-Durables Peterborough, Canada 0000
00000000 Pharmaceuticals Toronto, Canada 0000
To view this company’s complete subsidiary history, request access »

MPX International Executive Team (9)

Name Title Board
Seat
Contact
Info
Scott Boyes Chief Executive Officer, Chairman, President & Member of Audit Committee
David McLaren Chief Financial Officer
Michael Arnkvarn Chief Operating Officer - Canada
Daniel Fryer Managing Director, Europe
Randall Stafford Director, Finance & Board Member

3 Former Executives

You’re viewing 5 of 9 executives. Get the full list »

MPX International Board Members (2)

Name Representing Role Since Contact
Info
000000 0000 00 MPX International Executive Vice President, General Counsel, Corporate Secretary & Board Member 000 0000
0000000 00000000 MPX International Director, Finance & Board Member 000 0000